Research the Cure webinar September 2024 – eMSCs in RDEB

We were delighted to have Prof Katsuto Tamai from Osaka University to talk about his novel approach to treating severe dystrophic epidermolysis bullosa.

Prof Tamai outlined his research into gene-modified blister fluid-derived mesenchymal stromal cells (MSCs) to treat RDEB.

Further reading: Gene-Modified Blister Fluid-Derived Mesenchymal Stromal Cells for Treating Recessive Dystrophic Epidermolysis Bullosa

Thank you to everyone who attended. If you have any feedback on the webinar, or if there are topics that you would like to see covered at future research webinars, please do get in touch.

Our webinars are open to everyone – to find out about upcoming webinars, visit our Research Events

Thank you to Chiesi for the provision of an arm’s length educational grant to support this webinar series.